glp-1 and prostate cancer GLP-1s appear to cut risk. Researchers are asking why how : NPR GLP1 Receptor Agonists—Effects beyond Obesity

Type 2 diabetes holds a value of USD 1.4 billion with 16.2% CAGR

Yes, and heres why its worth it

Ethics declarations Competing interests C.S.W

The peptide transformation stories shared by community members often touch on the holistic nature of peptide-supported health journeys

Considering these changes in T2DM and the critical role of GLP-1 in glucose homeostasis, strategies for managing T2DM based on this hormone include addressing the differentiation of L-cells, increasing the endogenous production and secretion of GLP-1 through stimulants, extending the half-life of GLP-1 by inhibiting its degrading enzyme and targeting GLP-1R using its agonists